| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:28636814; PMID:31781319 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:35964836 |
| GO:0001510 | Rna methylation | Affects phenotype | PMID:39405678 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:34453993; PMID:35964836 |
| GO:0001837 | Epithelial to mesenchymal transition | Increases phenotype | PMID:35124418 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:36791901; PMID:37442281; PMID:39405678 |
| GO:0003729 | Mrna binding | Affects phenotype | PMID:32406909 |
| GO:0003730 | Mrna 3'-utr binding | Increases phenotype | PMID:23824327 |
| GO:0004096 | Catalase activity | Decreases phenotype | PMID:39798443 |
| GO:0004197 | Cysteine-type endopeptidase activity | Increases phenotype | PMID:23968587 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:29572906 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:29324385; PMID:39798443 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:34339004; PMID:39798443 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:29596344; PMID:31935557; PMID:32030632; PMID:34339004; PMID:39798443 |
| GO:0005977 | Glycogen metabolic process | Affects phenotype | PMID:31935557 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:31935557 |
| GO:0006096 | Glycolytic process | Increases phenotype | PMID:38485781 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:22572560; PMID:29572906; PMID:38563870 |
| GO:0006338 | Chromatin remodeling | Increases phenotype | PMID:25281835; PMID:34453993 |
| GO:0006412 | Translation | Decreases phenotype | PMID:23086926; PMID:23824327; PMID:32406909; PMID:34390821 |
| GO:0006413 | Translational initiation | Decreases phenotype | PMID:23396362; PMID:23824327 |
| GO:0006480 | N-terminal protein amino acid methylation | Increases phenotype | PMID:23978223 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:38703806 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:36534342 |
| GO:0006611 | Protein export from nucleus | Affects phenotype | PMID:33129825 |
| GO:0006635 | Fatty acid beta-oxidation | Decreases phenotype | PMID:39620 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:34339004 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:28688901; PMID:28688901; PMID:32030632; PMID:31272005; PMID:32030632; PMID:34339004; PMID:36343453; PMID:36791901 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:24024143; PMID:29324385; PMID:29596344 |
| GO:0006805 | Xenobiotic metabolic process | Affects phenotype | PMID:25194983 |
| GO:0006839 | Mitochondrial transport | Decreases phenotype | PMID:24315374 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:26677073; PMID:34453993; PMID:35964836; PMID:37659621 |
| GO:0006909 | Phagocytosis | Decreases phenotype | PMID:28499612 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:33097607; PMID:34929507 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:11848479; PMID:12803490; PMID:22463588; PMID:23396362; PMID:26677073; PMID:29596344; PMID:32443253; PMID:32980394; PMID:37046073 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:24190502; PMID:29324385; PMID:32030632 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:25547999; PMID:9057100 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:29982692 |
| GO:0007631 | Feeding behavior | Affects phenotype | PMID:37442281 |
| GO:0008219 | Cell death | Increases phenotype | PMID:22463588; PMID:26375285; PMID:34390821; PMID:37442281 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:23744399; PMID:24473123; PMID:26677073; PMID:28444938; PMID:35124418; PMID:38485781; PMID:38563870 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:28688901; PMID:31773452 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:24960579; PMID:29566083; PMID:29572906 |
| GO:0009060 | Aerobic respiration | Increases phenotype | PMID:28956099 |
| GO:0010606 | Positive regulation of cytoplasmic mrna processing body assembly | Increases phenotype | PMID:25409157 |
| GO:0010823 | Negative regulation of mitochondrion organization | Increases phenotype | PMID:24960579 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:28739695 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:25547999 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:16479312; PMID:25567531; PMID:30177839 |
| GO:0010976 | Positive regulation of neuron projection development | Increases phenotype | PMID:25547999 |
| GO:0014852 | Regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction | Affects phenotype | PMID:24960579 |
| GO:0015700 | Arsenite transport | Decreases phenotype | PMID:29324385 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:29324385; PMID:34339004 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:23534459; PMID:29324385; PMID:29596344 |
| GO:0016078 | Trna catabolic process | Increases phenotype | PMID:23086926 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:31272005 |
| GO:0016567 | Protein ubiquitination | Increases phenotype | PMID:29324385 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:38703806 |
| GO:0019722 | Calcium-mediated signaling | Decreases phenotype | PMID:12803490 |
| GO:0030101 | Natural killer cell activation | Increases phenotype | PMID:33301752 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:31272005 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:38703806; PMID:38703806; PMID:39405678; PMID:39405678 |
| GO:0030262 | Apoptotic nuclear changes | Increases phenotype | PMID:35964836 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:28688901; PMID:31773452 |
| GO:0031589 | Cell-substrate adhesion | Decreases phenotype | PMID:35124418; PMID:38563870 |
| GO:0032043 | Mitochondrial dna catabolic process | Increases phenotype | PMID:25547999 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:9057100 |
| GO:0032148 | Activation of protein kinase b activity | Increases phenotype | PMID:28952001 |
| GO:0032227 | Negative regulation of synaptic transmission, dopaminergic | Increases phenotype | PMID:29982692 |
| GO:0032780 | Negative regulation of atp-dependent activity | Increases phenotype | PMID:26677073 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:24960579 |
| GO:0032963 | Collagen metabolic process | Affects phenotype | PMID:38703806 |
| GO:0033192 | Calmodulin-dependent protein phosphatase activity | Decreases phenotype | PMID:22564430 |
| GO:0034063 | Stress granule assembly | Increases phenotype | PMID:23279204; PMID:23279204; PMID:34244458; PMID:34390821; PMID:34469566; PMID:23824327; PMID:34244458; PMID:34390821; PMID:34469566; PMID:36534342; PMID:38734221 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:29572906; PMID:36791901; PMID:39798443 |
| GO:0035733 | Hepatic stellate cell activation | Increases phenotype | PMID:31513886 |
| GO:0038001 | Paracrine signaling | Increases phenotype | PMID:31513886 |
| GO:0042116 | Macrophage activation | Increases phenotype | PMID:33080309; PMID:35777529 |
| GO:0042541 | Hemoglobin biosynthetic process | Increases phenotype | PMID:23369756 |
| GO:0042554 | Superoxide anion generation | Affects phenotype | PMID:34339004 |
| GO:0042593 | Glucose homeostasis | Affects phenotype | PMID:28952001 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:37442281 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:15316071; PMID:24457827 |
| GO:0043984 | Histone h4-k16 acetylation | Decreases phenotype | PMID:25281835; PMID:28837777 |
| GO:0044127 | Regulation of development of symbiont in host | Affects phenotype | PMID:26529668 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:22447124; PMID:22463588; PMID:23968587; PMID:31272005; PMID:31934280; PMID:32030632; PMID:32443253; PMID:32980394; PMID:34453993; PMID:34678219; PMID:34929507; PMID:35964836; PMID:38485781; PMID:38630284; PMID:38703806; PMID:39798443 |
| GO:0044255 | Cellular lipid metabolic process | Affects phenotype | PMID:30376133 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:31616959; PMID:35124418; PMID:38485781 |
| GO:0044399 | Multi-species biofilm formation | Affects phenotype | PMID:26529668 |
| GO:0044754 | Autolysosome | Increases phenotype | PMID:31781319 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:28688901 |
| GO:0045666 | Positive regulation of neuron differentiation | Increases phenotype | PMID:25547999 |
| GO:0045725 | Positive regulation of glycogen biosynthetic process | Increases phenotype | PMID:28952001 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:29572906 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:23744399; PMID:24184494 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:28688901 |
| GO:0046459 | Short-chain fatty acid metabolic process | Affects phenotype | PMID:36791901 |
| GO:0048027 | Mrna 5'-utr binding | Increases phenotype | PMID:23824327 |
| GO:0048709 | Oligodendrocyte differentiation | Decreases phenotype | PMID:31272005 |
| GO:0051000 | Positive regulation of nitric-oxide synthase activity | Increases phenotype | PMID:28688901 |
| GO:0051091 | Positive regulation of dna-binding transcription factor activity | Increases phenotype | PMID:11299744; PMID:30177839 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:30177839 |
| GO:0051173 | Positive regulation of nitrogen compound metabolic process | Increases phenotype | PMID:26529668 |
| GO:0051348 | Negative regulation of transferase activity | Affects phenotype | PMID:29572906 |
| GO:0051560 | Mitochondrial calcium ion homeostasis | Affects phenotype | PMID:34453993 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:23744399; PMID:26677073; PMID:35964836 |
| GO:0051973 | Positive regulation of telomerase activity | Affects phenotype | PMID:27470698 |
| GO:0055088 | Lipid homeostasis | Affects phenotype | PMID:30376133 |
| GO:0060212 | Negative regulation of nuclear-transcribed mrna poly(a) tail shortening | Increases phenotype | PMID:25446091 |
| GO:0060317 | Cardiac epithelial to mesenchymal transition | Decreases phenotype | PMID:26354774 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:31781319; PMID:38485781 |
| GO:0060390 | Regulation of smad protein signal transduction | Affects phenotype | PMID:26354774 |
| GO:0061179 | Negative regulation of insulin secretion involved in cellular response to glucose stimulus | Increases phenotype | PMID:28956099 |
| GO:0061909 | Autophagosome-lysosome fusion | Decreases phenotype | PMID:31781319 |
| GO:0062029 | Positive regulation of stress granule assembly | Increases phenotype | PMID:24183723; PMID:25409157; PMID:26115353 |
| GO:0070372 | Regulation of erk1 and erk2 cascade | Decreases phenotype | PMID:25145660 |
| GO:0070374 | Positive regulation of erk1 and erk2 cascade | Increases phenotype | PMID:23618899; PMID:25493652 |
| GO:0070509 | Calcium ion import | Affects phenotype | PMID:31332465 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:22240577; PMID:32030632; PMID:36791901 |
| GO:0071243 | Cellular response to arsenic-containing substance | Affects phenotype | PMID:31355259; PMID:37759824 |
| GO:0071478 | Cellular response to radiation | Increases phenotype | PMID:28739695 |
| GO:0071493 | Cellular response to uv-b | Affects phenotype | PMID:22463588 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:24184494; PMID:31781319; PMID:31935557; PMID:32030632; PMID:32980394; PMID:33451022; PMID:34453993; PMID:34798142; PMID:35964836; PMID:35964836; PMID:37659621; PMID:36343453; PMID:37659621; PMID:38630284 |
| GO:0072676 | Lymphocyte migration | Increases phenotype | PMID:36791901 |
| GO:0080009 | Mrna methylation | Increases phenotype | PMID:29982692 |
| GO:0090398 | Cellular senescence | Increases phenotype | PMID:39405678 |
| GO:0097272 | Ammonium homeostasis | Affects phenotype | PMID:38703806 |
| GO:0098609 | Cell-cell adhesion | Increases phenotype | PMID:31781319; PMID:32076005 |
| GO:0099156 | Cell-cell signaling via exosome | Increases phenotype | PMID:31513886 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:35777529 |
| GO:1900182 | Positive regulation of protein localization to nucleus | Increases phenotype | PMID:29572906 |
| GO:1901485 | Positive regulation of transcription factor catabolic process | Increases phenotype | PMID:25493652 |
| GO:1901605 | Alpha-amino acid metabolic process | Increases phenotype | PMID:26529668 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:28688901; PMID:29572906 |
| GO:1901684 | Arsenate ion transmembrane transport | Decreases phenotype | PMID:11509741 |
| GO:1902310 | Positive regulation of peptidyl-serine dephosphorylation | Increases phenotype | PMID:24942733 |
| GO:1902883 | Negative regulation of response to oxidative stress | Increases phenotype | PMID:24960579 |
| GO:1903071 | Positive regulation of er-associated ubiquitin-dependent protein catabolic process | Increases phenotype | PMID:25701757 |
| GO:1903180 | Negative regulation of dopamine biosynthetic process | Increases phenotype | PMID:29982692 |
| GO:1903209 | Positive regulation of oxidative stress-induced cell death | Increases phenotype | PMID:25701757 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:23744399 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:25547999; PMID:27470698 |
| GO:1903599 | Positive regulation of autophagy of mitochondrion | Increases phenotype | PMID:24960579 |
| GO:1903608 | Protein localization to cytoplasmic stress granule | Increases phenotype | PMID:23341463 |
| GO:1903626 | Positive regulation of dna catabolic process | Increases phenotype | PMID:29572906 |
| GO:1903703 | Enterocyte differentiation | Affects phenotype | PMID:38563870 |
| GO:1904206 | Positive regulation of skeletal muscle hypertrophy | Increases phenotype | PMID:24960579 |
| GO:1905267 | Endonucleolytic cleavage involved in trna processing | Increases phenotype | PMID:29431851 |
| GO:1905538 | Polysome binding | Affects phenotype | PMID:32406909 |
| GO:1905898 | Positive regulation of response to endoplasmic reticulum stress | Increases phenotype | PMID:25547999 |
| GO:1990051 | Activation of protein kinase c activity | Increases phenotype | PMID:9057100 |
| GO:1990182 | Exosomal secretion | Increases phenotype | PMID:31513886 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:36791901 |
| GO:1990428 | Mirna transport | Increases phenotype | PMID:33080309 |
| GO:1990764 | Myofibroblast contraction | Increases phenotype | PMID:38703806 |
| GO:1990922 | Hepatic stellate cell proliferation | Increases phenotype | PMID:31513886 |
| GO:2000277 | Positive regulation of oxidative phosphorylation uncoupler activity | Increases phenotype | PMID:24960579 |
| GO:2000324 | Positive regulation of glucocorticoid receptor signaling pathway | Increases phenotype | PMID:2298732 |
| GO:2000376 | Positive regulation of oxygen metabolic process | Increases phenotype | PMID:24960579 |
| GO:2000573 | Positive regulation of dna biosynthetic process | Increases phenotype | PMID:28688901 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.